Cite
HARVARD Citation
Dickinson, L. et al. (n.d.). Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study. Clinical pharmacology & therapeutics. 98 (4), pp. 406-416. [Online].